This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Timothy Batchelder, MD
Richmond, Calif

Michael Barricks, MD
Oakland, Calif

Arch Ophthalmol. 1995;113(6):702-703.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In the September 1994 issue of the ARCHIVES, Klein et al¹ conclude that their study confirms current guidelines for ophthalmologic care of patients with diabetes. After a thorough review of their data, we think that their results contradict the guideline that all people with diabetes need annual screening examinations. The annual examination standard does not reflect the findings of Klein et al^1-4 that the risk of treatable retinopathy depends on the status of the retina at a baseline examination. We conclude that the data of Klein et al¹ support a screening interval of 2 years or more, depending on the sensitivity of the method, for patients with retinopathy levels 21 or less at their last examination.

Tables 7 and 8 in the article by Klein et al¹ show that among 708 patients with no retinopathy at baseline, in only 1.2% to 2.5% did proliferative diabetic retinopathy . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?